COREVALVE TRANSCATHETER AORTIC VALVE
Report
- Report Number
- 2025587-2017-02105
- Event Type
- Injury
- Date Received
- November 14, 2017
- Date of Event
- May 1, 2015
- Report Date
- November 14, 2017
- Manufacturer
- MEDTRONIC HEART VALVES DIVISION
- Product Code
- NPT
- PMA / PMN Number
- P130021
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
CITATION: FRERKER C. EXPANSION OF THE INDICATION OF TRANSCATHETER AORTIC VALVE IMPLANTATION--FEASIBILITY AND OUTCOME IN "OFF-LABEL" PATIENTS COMPARED WITH "ON-LABEL" PATIENTS. J INVASIVE CARDIOL. MAY 2015; 27(5):229-36 EARLIEST DATE OF PUBLISH USED FOR EVENT DATE. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT COULD NOT BE DETERMINED WHETHER THESE OBSERVATIONS HAVE BEEN PREVIOUSLY REPORTED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.
MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REGARDING OUTCOMES OF PERFORMING TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI). ALL DATA WERE COLLECTED FROM A SINGLE CENTER BETWEEN 2008 AND 2012. THE STUDY POPULATION INCLUDED 591 PATIENTS (PREDOMINANTLY FEMALE; MEAN AGE 80 YEARS), 343 OF WHICH WERE IMPLANTED WITH MEDTRONIC COREVALVE (SERIAL NUMBERS NOT PROVIDED). AMONG ALL PATIENTS ADVERSE EVENTS INCLUDED: VALVE EMBOLIZATION, MODERATE AORTIC REGURGITATION, PARAVALVULAR LEAK (PVL), VALVE-IN-VALVE, PERMANENT PACEMAKER IMPLANT, STROKE, CARDIOPULMONARY BYPASS (CPB), AND VASCULAR COMPLICATIONS. MULTIPLE MANUFACTURERS WERE NOTED IN THE LITERATURE; BASED ON THE AVAILABLE INFORMATION A DIRECT CORRELATION COULD NOT BE MADE BETWEEN THE OBSERVED ADVERSE EVENTS AND MEDTRONIC PRODUCT. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 808249 | COREVALVE TRANSCATHETER AORTIC VALVE | AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED | NPT | MEDTRONIC HEART VALVES DIVISION | CRS |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 80 YR | Required Intervention |